| December 3 |
FDA Advisors Declare 'FDA Science and Mission at Risk' |
| December 3 |
Bruker BioSciences Corporation Announces Agreement to Acquire the
Bruker BioSpin Group for $914 Million in Cash and Stock |
| December 3 |
Evotec Completes Divesture of Chemical Development Business to
Aptuit |
| December 3 |
Santarus Licenses Rights to GlaxoSmithKline for Zegerid
Immediate-Release Omeprazole Products in over 100 Countries |
| December 3 |
StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy,
LLC |
| December 3 |
Addex and Merck & Co., Inc. Collaborate to Develop Drugs for
Parkinson's Disease |
| December 3 |
Do Medical Schools Affect the Way Future Doctors Interact with Drug
Companies? |
| December 3 |
Sanofi-Aventis Inaugurates First Asian Development Centre for
Pharmaceuticals in Goa, India |
| December 3 |
Novartis Further Strengthens Biologics Capabilities in Expansion of
MorphoSys Collaboration |
| December 3 |
MorphoSys and Novartis Forge New Strategic Alliance to Establish
Innovative Therapeutic Antibody Pipeline |
| December 3 |
King Pharmaceuticals Reports Petition for Rehearing and Rehearing
En Banc Denied |
| December 4 |
Merck Anticipates Earnings per Share Growth in 2008; Reaffirms
Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to
2010, Excluding Certain Items |
| December 4 |
Watson and Biovail Settle Lawsuit Over Cardizem LA |
| December 4 |
Decision Resources Inc. to Acquire Wood Mackenzie's Life Sciences
Business |
| December 4 |
Edgeline Holdings Announces the Acquisition of Intertech Bio Has
Been Completed |
| December 4 |
HBIO Divests the Majority of its Capital Equipment Business |
| December 4 |
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir
Disoproxil Fumarate Tablets |
| December 4 |
AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug
Response Project |
| December 4 |
Rep. Waxman Urges Strong Response to Report on FDA Resource
Shortfalls |
| December 4 |
Anika Therapeutics and Galderma Complete Termination of License,
Development and Supply Agreements |
| December 4 |
Compendia Bioscience Signs Oncomine Licensing Agreement with
AstraZeneca |
| December 4 |
Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur |
| December 4 |
Eisai and BioArctic Neuroscience Enter Exclusive Licensing
Agreement with Novel Antibody Treatment for Alzheimer's Disease |
| December 4 |
FDA MedWatch - Desmopressin Acetate - Product Labeling Updated To
Include Important New Information About Severe Hyponatremia And
Seizures |
| December 4 |
Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest
AG |
| December 4 |
Bruker BioSciences Corporation Announces Agreement to Acquire the
Bruker BioSpin Group for $914 Million in Cash and Stock |
| December 5 |
Amarin Signs Agreement to Acquire Ester Neurosciences |
| December 5 |
Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to
Develop and Commercialize Novel Pain Compounds |
| December 5 |
Synta Receives $80 Million Upfront Payment from GlaxoSmithKline |
| December 5 |
Revolution Health Acquires HealthTalk |
| December 5 |
Akorn, Inc. Announces First ANDA Submission For Serum Institute of
India, Ltd. |
| December 5 |
Chemokine Therapeutics Withdraws Registration Statement and
Implements a Cost Reduction Plan |
| December 5 |
Bristol-Myers Squibb Announces Closing Of Its Colón, Panama
Manufacturing Facility |
| December 5 |
R&D Tax Credit Essential for a Healthier America |
| December 5 |
Bristol-Myers Squibb Company Outlines Strategy and Productivity
Transformation Initiative During Update to Investment Community |
| December 5 |
Kentucky Pharmacists Event Urging Senate Minority Leader McConnell
to Fix Flawed Medicaid Drug Reimbursement Rule |
| December 6 |
Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008
Financial Guidance and Outlines Transformation Strategy |
| December 6 |
IMPAX Submits Additional Information to FDA Related to ANDA For
Generic Version of Opana ER |
| December 6 |
BioCryst Provides Forodesine HCl Update |
| December 6 |
Michigan Health Plans Continue Focus on Generics for Cost Savings |
| December 6 |
Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend
Evaluation Period of Selected Raven Antibodies |
| December 6 |
Sun Pharma Announces Settlement of Litigation Over Generic Exelon |
| December 6 |
Video and Photo: EMD Serono Launches easypod, New Electronic Growth
Hormone Injection Device |
| December 6 |
Sepragen Announces the Completion of Cyto Biologic Technologies
Acquisition |
| December 6 |
ATEL Ventures Portfolio Company, ARYx Therapeutics, Inc. Completes
Initial Public Offering |
| December 6 |
Safety Concerns Prompt Prime to Remove Avandia from Formulary |
| December 6 |
Introducing the Brand New Report on Business Strategies for
Different Types of Biogenerics |
| December 6 |
QPS Announces Signing Agreement to Acquire Bio-Kinetic Clinical
Applications, Gaining Phase I and Early Clinical Services |
| December 6 |
NCPA Testifies Before House Small Business Committee |
| December 7 |
Watson and Novartis Settle Lawsuit Over Exelon Patent Litigation |
| December 7 |
Watson and Novartis Settle Lawsuit Over Exelon Patent Litigation |
| December 7 |
Amgen in Discussions with FDA to Update U.S. Prescribing
Information for ESAs |
| December 7 |
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and
Interim Chief Executive Officer |
| December 7 |
AstraZeneca Presents its Global Biologics Organization, MedImmune,
at 2007 Analyst and Investor R&D Day |
| December 7 |
Nationwide Survey Reveals Differing Physician and Patient
Perceptions Regarding Impact of Ulcerative Colitis on Patients'
Lives |
| December 7 |
Cardinal Health to Cease Distribution of Controlled Substances from
Florida Facility |
| December 7 |
ImClone and Sanofi-Aventis Settle Patent Litigation with Yeda
Research and Development Corporation |
| December 10 |
GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance
to Develop Cancer Stem Cell Antibody Therapeutics |
| December 10 |
Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser |
| December 10 |
Meda: Competition Authority Approves Meda's Acquisition of Recip |
| December 10 |
Eisai to Acquire MGI Pharmafor $41 Per Share in an All Cash
Transaction |
| December 10 |
Thalidomide Added to Standard Therapy Prolongs Overall Survival in
Newly Diagnosed Multiple Myeloma Patients Over Age 75 |
| December 10 |
New Data Show Glivec Halts Progression to Advanced Stages of
Life-threatening Form of Leukemia in Sixth Year of Treatment |
| December 10 |
Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets
Primary Endpoints |
| December 10 |
Acura Pharmaceuticals, Inc. Announces Receipt of $30 Million Cash
Payment and Closing of Agreement With King Pharmaceuticals |
| December 10 |
Pivotal Phase III Data Showed Rivaroxaban Was Statistically
Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE)
in Patients Following Hip Replacement Surgery |
| December 10 |
ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc. |
| December 10 |
New Report Offers Hope for Closing Health Gap for African
Americans, With Nearly 700 Medicines in Pipeline |
| December 10 |
FDA's Safety Reviews of Prilosec and Nexium Find No Evidence of
Increased Rates of Cardiac Events |
| December 10 |
Commonwealth Biotechnologies Completes Integration Program for its
Complementary Drug Discovery Businesses |
| December 11 |
Novo Nordisk Settles With Pfizer On Patent Infringement Suit |
| December 11 |
Novo Nordisk Settles With Pfizer On Patent Infringement Suit |
| December 11 |
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to
Include Commercialization of Atripla (efavirenz 600
mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in
Europe |
| December 11 |
Replidyne Provides Strategic Update |
| December 11 |
Trimeris Announces 2008 Strategic Plan |
| December 11 |
Biovail Announces Proposed Settlement of U.S. Securities Class
Action |
| December 11 |
Merck Reviews Progress on Strategic Plan at 2007 Annual Business
Briefing |
| December 11 |
First New Opioid Dependence Treatment in More Than 30 years |
| December 12 |
AstraZeneca Files Patent Infringement Actions in Response to
Crestor ANDAs |
| December 12 |
AstraZeneca Files Patent Infringement Actions in Response to
Crestor ANDAs |
| December 12 |
West Pharmaceutical Services Announces Restructuring Plan for Tech
Group |
| December 12 |
Survey Finds At-Risk Consumers Interested in OTC Statin |
| December 12 |
Use of Diabetes Medication by Older Adults Associated with
Increased Risk of Serious Heart Problems, Death |
| December 12 |
Influenza Pandemic Could Cost Canadian Economy $9 Billion |
| December 12 |
Three Lots of Measles, Mumps and Rubella Vaccine Suspended from Use |
| December 12 |
Generic Prescription Drugs Show Increasingly Greater Use in
Southeastern Pennsylvania |
| December 12 |
Medicis and Revance Announce Strategic Collaboration |
| December 12 |
FDA Issues an FDA Alert and Information for Healthcare
Professionals Sheet for Carbamazepine |
| December 12 |
MPM BioEquities Demands VaxGen Drop Merger Plan with Raven |
| December 12 |
Celsion Purchases 659,738 Shares of Celsion Common Stock from
Boston Scientific |
| December 13 |
Biogen Idec Completes Review of Strategic Alternatives |
| December 13 |
Court Grants Depomed's Motion for Summary Judgment of Patent
Infringement Against IVAX |
| December 13 |
Shire plc: Board Changes |
| December 13 |
Merck Announces Voluntary Recall of Certain Lots of Pedvaxhib and
Comvax |
| December 13 |
Solvay Pharmaceuticals, Inc. Responds to Advisory Committee
Recommendation for Further Study of Tedisamil to Treat Atrial
Fibrillation |
| December 13 |
Elan Update |
| December 13 |
European Pharmaceutical Industry is Key to Helping Eu Become the
Most Competitive and Dynamic Knowledge-based Society in the World |
| December 13 |
Odyssey Thera Receives Milestone Payments in Pfizer Collaboration |
| December 13 |
Cholesterol-Lowering Drugs and the Risk of Hemorrhagic Stroke |
| December 13 |
Novartis Launches Strategic Initiative to Improve Competitiveness
in a Dynamically Changing Healthcare Environment |
| December 13 |
The Labeling for Exjade (deferasirox) has Been Changed to Include
Information about Postmarketing Reports of Hepatic Failure, Some
with a Fatal Outcome |
| December 14 |
Neurocrine Announces Work Force Restructuring |
| December 14 |
FDA Advisory Panel Recommends Against Approval of Merck's NDA for
Non-prescription Mevacor (lovastatin) 20 mg |
| December 14 |
GlaxoSmithKline, Via Its Center of Excellence for External Drug
Discovery, Exercises Its Option to Further Develop and
Commercialize Exelixis' Anti-Cancer C-MET Inhibitor XL880 |
| December 14 |
European Medicines Agency Concludes New Advice to Doctors and
Patients for Champix Needed |
| December 14 |
European Medicines Agency Recommends Withdrawal of the Marketing
Authorisations for Lumiracoxib-Containing Medicines |
| December 14 |
Committee for Medicinal Products for Human Use Post-authorisation
Summary of Positive Opinion for Humira |
| December 14 |
Merck Settles Clean Water Act Violations at its Montgomery County,
Pennsylvania Pharmaceutical Plant |
| December 14 |
I-Flow Announces Agreement to Acquire AcryMed, Inc. |
| December 14 |
Boston Scientific Agrees To Sell Fluid Management and Venous Access
Businesses to Avista Capital Partners for $425 Million |
| December 14 |
FDA Sends Wyeth Warning Letter Over Effexor Ad |
| December 17 |
Oxford Genome Sciences and Amgen to Jointly Discover Novel
Therapeutic Antibodies in Cancer |
| December 17 |
Highly Promising Dutch Research Into Alzheimer's Disease and
Parkinson's Disease |
| December 17 |
Gene Logic Inc. Completes Sale of Genomics Assets to Ocimum
Biosolutions |
| December 17 |
HBIO Board Unanimously Rejects Skystone's Offer to Acquire the
Company. |
| December 17 |
Defense Threat Reduction Agency Halts Contract Negotiations With
Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008
Budget for Its Transformational Medical Technologies Initiative
(TMTI) Program |
| December 17 |
OncoVista Increases Its Share in AdnaGen AG |
| December 17 |
Ambrx Announces Drug Discovery Alliance With Eli Lilly and Company |
| December 17 |
Oncothyreon to Receive $5 Million Payment |
| December 17 |
Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb
Medical Imaging for Approximately $525 Million |
| December 17 |
FDA Announces Updated Information Regarding Antiretroviral Agents
Used as HIV Postexposure Prophylaxis for Occupational HIV Exposures |
| December 17 |
Aspreva Obtains Shareholder Approval for Acquisition by Galenica |
| December 18 |
Lilly and BioMS Medical Announce Global Licensing and Development
Agreement |
| December 18 |
Galapagos Announces Milestone Payment of €7.5 Million in
Osteoarthritis Alliance with Glaxosmithkline |
| December 18 |
Astellas Pharma Inc. and Toray Industries, Inc. Launch PAH Agent in
Japan |
| December 18 |
Eisai Enters Into In-licensing Agreement with Minophagen
Pharmaceutical for Liver Disease/Allergic Disease AgentsStronger
Neo-Minophagen C and Glycyron Tablets |
| December 18 |
Lu AA21004 For the Treatment of Mood and Anxiety Disorders Enters
Into Clinical Phase III |
| December 18 |
Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as
Successor |
| December 18 |
PM Announces Canada’s New Food and Consumer Safety Action
Plan |
| December 18 |
Pfizer to Acquire CovX to Extend Biotherapeutics Investment |
| December 18 |
BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono |
| December 18 |
ActivBiotics Sells Proprietary Assets, Including Drug Product
Candidates |
| December 19 |
FDA Grants Tentative Approval to First Generic for Antiretroviral
Viread |
| December 19 |
Idera Pharmaceuticals and Merck KGaA to Collaborate on Development
of TLR9 Agonists for Treatment of Cancer |
| December 19 |
Pharmos Corporation Announces President & COO Alan L. Rubino to
Leave Company |
| December 19 |
Decision Resources, Inc. Acquires Arlington Medical Resources, Inc. |
| December 19 |
GlaxoSmithKline Completes Acquisition of Reliant Pharmaceuticals |
| December 19 |
Alkermes Announces Receipt of $166 Million from Sale of Stake in
Reliant Pharmaceuticals |
| December 19 |
Antisense Pharma With New Management Structure |
| December 19 |
Galapagos Announces Osteoporosis Collaboration with Lilly |
| December 19 |
Biogen Idec Announces First Startup in Its Innovation Incubator |
| December 19 |
AstraZeneca and Banner Alzheimer's Institute Collaborate to
Evaluate New Tool Targeting Alzheimer's Disease |
| December 19 |
DSM Dyneema to Become Separately Reporting Business Group |
| December 19 |
Enzo Biochem Unit Signs Letter of Intent to Acquire Belgian Life
Sciences Distributor |
| December 20 |
Akela Pharma Provides Corporate Update |
| December 20 |
Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb |
| December 20 |
Merck Serono and Flamel to Collaborate on an Extended Release
Formulation for Therapeutic Proteins |
| December 20 |
Lonza Withdraws Majority of Claims in Patent Lawsuit Against
Northwest Biotherapeutics |
| December 20 |
Compugen and Roche Sign Agreement to Identify Genetic Variations
Predictive of Drug Response in Rheumatoid Arthritis Patients |
| December 20 |
Hemispherx Biopharma Comments on 2005 BDO Audit News |
| December 20 |
Valeant Pharmaceuticals Sells Hep-C Drug Infergen to Three Rivers
Pharmaceuticals, LLC for $91 Million |
| December 20 |
Altus Pharmaceuticals Reacquires ALTU-238 Global Development and
Commercialzation Rights |
| December 20 |
Marketing of Viadur (leuprolide acetate implant) to Phase Out by
April 2008 |
| December 20 |
Thermo Fisher Scientific Acquires Leading Chromatography
Consumables Provider, La-Pha-Pack |
| December 20 |
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines |
| December 20 |
Scripps Research Discovery Leads to Broad Potential Applications in
CovX-Pfizer Deal |
| December 20 |
Regeneron Closes $312 Million Common Stock Sale in Connection with
Sanofi-Aventis Collaboration |
| December 20 |
Agilent Technologies Completes Acquisition of Velocity11, a Leader
in Life Science Lab Automation and Robotics |
| December 21 |
Avastin Press Statement |
| December 21 |
Daiichi Sankyo to Dissolve Subsidiary |
| December 21 |
Daiichi Sankyo Announces Merger of Subsidiaries |
| December 21 |
Lundbeck Expands Agreement with Paion for Desmoteplase |
| December 21 |
FDA MedWatch - Fentanyl Transdermal System - Updated Information On
Appropriate Prescribing, Dose Selection, and Safe Use |
| December 21 |
Public Communication - Health Canada Endorsed Important Safety
Information on Alertec (modafinil) |
| December 21 |
Quintiles Transnational Forms New Ownership Team with Current
Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i |
| December 26 |
Wyeth Will Pursue Claim for Damages Resulting From Teva
Pharmaceuticals' Launch of Generic Pantoprazole in Violation of
Protonix Patent |
| December 26 |
Transition Therapeutics Announces Milestone Payment from Elan |
| December 26 |
Cubist Pharmaceuticals Acquires Illumigen Biosciences |
| December 26 |
Eisai Introduces New Aricept Dose Formulations for Treatment of
Severe Alzheimer's Disease in Japan |
| December 26 |
IMS Health, Wolters Kluwer Health and Verispan Comment on Federal
Judge's Decision to Grant Preliminary Injunction Blocking
Enforcement of Maine Prescription Restraint Law |
| December 26 |
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold |
| December 27 |
U.S. District Court Decision About Eisai's Legal Action Over
Aricept ODT ANDA Filing |
| December 27 |
MultiCell Technologies To Increase Focus on Therapeutic Candidates |
| December 27 |
Notice of Conversion Right for Senior Subordinated Convertible
Notes Due 2024 |
| December 27 |
Astellas Won the Patent Infringement Suit on Oral Cephalosporin
Antibiotic Cefzon Capsule |
| December 27 |
Three Steps to Boost Asymchem's Investment in China |
| December 27 |
MedCap Opposes VaxGen's Proposed Merger with Raven biotechnologies |
| December 27 |
The Medical House PLC Announces Disposal of Loss-Making
Sub-contract Machining Division |
| December 27 |
Cell Therapeutics, Inc. Completes Acquisition of Lymphoma Drug
Zevalin From Biogen Idec for Sales and Marketing in the United
States |
| December 27 |
Exelgen Announces Partnerships with Two Leading European
Biotechnology Companies |
| December 27 |
Columbia River Resources Inc. Acquires Cutting-Edge Pharmaceutical
RFID Company |
| December 28 |
Millennium to Receive $40 Million Milestone Payment for Achievement
of Sales Threshold for Velcade (Bortezomib) for Injection |
| December 28 |
Inflazyme Pharmaceuticals Announces Departure of Senior Management |
| December 28 |
New Private and Government Sector Projects at CBI Services |
